High-risk molecular subtypes include DLBCLs with MYC and BCL2 and/or BCL6 rearrangements (“double-hit” or “triple-hit” lymphomas), now classified as high-grade B-cell lymphoma (HGBCL-DH/TH) by the World Health Organization. The gene discussed is MYC; the disease is lymphoma.